News

In contrast to the several animal models of MPO-ANCA-associated vasculitis, a satisfying model for PR3-ANCA-associated vasculitis that shows characteristics similar to human Wegener's ...
Targeting the complement pathway using a C5a agonist may be a “game changer” in anti-neutrophil cytoplasmic autoantibody vasculitis, according to a speaker at the Basic and Clinical Immunology ...
A middle-aged man was diagnosed with necrotizing scleritis associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and responded well to rituximab therapy, despite ...
In Cureus, physicians reported the case of a patient with hypertensive emergency who was later diagnosed with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). A 48-year-old ...
Non-ANCA small vessel vasculitides include: Vasculitis associated with paraneoplastic syndromes Those linked to immune complex deposition Henoch-Schonlein purpura Behcet’s disease ...
A better side-effect profile than cyclophosphamide may make MMF an agent worth considering in patients with refractory or recurrent ANCA-small-vessel vasculitis, a new pilot study suggests. (Joy S ...
The widespread use of screening for circulating anti-neutrophil cytoplasmic autoantibodies (ANCA) in the diagnosis of ANCA-associated vasculitis has resulted in an increased occurrence of false ...
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of rare disorders that cause swelling and damage to your blood vessels.
However, estimates of infection rates in ANCA-associated vasculitis have been wide, ranging from only 6% to as high as 67%, and most often have been limited to cases involving hospitalization.
ANCA vasculitis can affect blood vessels in your kidneys and other organs. It’s not common, but your doctor can run a blood test to find out.
The FDA approved the oral complement 5a receptor inhibitor avacopan (Tavneos) for the treatment of severe, active antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, drugmaker ...